Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
  • Oxolin
    ointment externally 
  • Stisamet®
    ointment locally externally 
  • Dosage form: & nbsp

    rectal suppositories

    Composition:

    For one suppository:

    Active substance: dioxomstiltetrahydropyrimidine (methyluracil) 500 mg.

    Excipient: solid fat - a sufficient amount to obtain a suppository with a mass of 2.3 g.

    Description:Suppositories white or white with a yellowish or kremovatym tinge, torpedo-shaped.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Has anabolic activity. Has hematopoietic, leukopoetic, immunostimulating, anti-inflammatory action. Normalizing the nucleic acid metabolism, accelerates the processes of cellular regeneration in wounds, accelerating the growth and granulation maturation of tissue and epithelization (including in rapidly proliferating cells of the gastrointestinal mucosa), stimulates erythro- and leukopoiesis, cellular and humoral immunity factors.

    Indications:

    Proctitis, sigmoiditis, ulcerative colitis.

    Contraindications:

    Hypersensitivity, leukemia (leukemia, especially myeloid), lymphogranulomatosis, hemoblastosis, malignant bone marrow diseases.

    This dosage form is not used in children under 8 years of age.
    Dosing and Administration:

    Rectal: adults - 500-1000 mg 3-4 times a day;

    children of 8-15 years - 500 mg per day.

    The course of treatment is from 7 days to 4 months, depending on the nature of the disease.

    Side effects:

    Allergic reactions, short-term mild burning.

    Form release / dosage:Suppositories rectal 500 mg
    Packaging:

    5 pieces per circuit cell packaging.

    Two contour packs together with the instruction for use are placed in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of no higher than 15 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the date shown on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-000760/10
    Date of registration:05.02.2010 / 03.07.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:ALTAYVITAMINS, CJSC ALTAYVITAMINS, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp08.05.2018
    Illustrated instructions
      Instructions
      Up